AI-001

N/A

Report date: 2023/01/08 14:04:05

Base Information

Drug NameAI-001
Drug Alias NameAI-001
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 1PsoriasisAlopecia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBirchbiomed IncThe University Of British Columbia
China Registration ClassN/A

Develop Information

Active CompaniesBirchbiomed IncThe University Of British Columbia
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1PsoriasisAlopecia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A